HLS Therapeutics Stock Quote HLS - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

3.24

Bid

3.13

Ask

3.27

Volume

0.00 Day's Range 0.00

3.07 52 Week Range 6.40

Market Cap

103.615M

Previous Close

3.24

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

12,963

Shares Outstanding

31,980,000

Dividend Yield

PE Ratio

-3.76

Earnings Per Share (EPS)

-0.86

Revenue

63.61M

Net Profit

-27.53M

Sector

Pharmaceutical Preparations

Industry

Motor Vehicle Part,accessory

Website

www.hlstherapeutics.com

Headquarters

Toronto, Ontario, Can

Founded

2018

HLS Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the Toronto Stock Exchange with ticker HLS. The last closing price for HLS Therapeutics was $3.24. Over the last year, HLS Therapeutics shares have traded in a share price range of $ 3.07 to $ 6.40.

HLS Therapeutics currently has 31,980,000 shares outstanding. The market capitalization of HLS Therapeutics is $103.62 million. HLS Therapeutics has a price to earnings ratio (PE ratio) of -3.76.

FeaturedSouthern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project

HLS Therapeutics to Host Q2 Fiscal 2024 Financial Results Conference Call

HLS Therapeutics to Host Q2 Fiscal 2024 Financial Results Conference Call Canada NewsWire TORONTO, July 25, 2024 TORONTO, July 25, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the...

HLS Therapeutics Announces the Sale of its XENPOZYME® Royalty Interest to DRI Healthcare Trust

HLS Therapeutics Announces the Sale of its XENPOZYME® Royalty Interest to DRI Healthcare Trust Canada NewsWire TORONTO, July 2, 2024 Total consideration of up to $45.75 million, which...

HLS Therapeutics Reports Annual Meeting Results

HLS Therapeutics Reports Annual Meeting Results Canada NewsWire TORONTO, June 7, 2024 TORONTO, June 7, 2024 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS...

Publication d'une nouvelle étude sur l'impact des programmes de soutien aux patients sur la persistance au traitement à la clozapine

Publication d'une nouvelle étude sur l'impact des programmes de soutien aux patients sur la persistance au traitement à la clozapine Canada NewsWire DORVAL, QC, le 28 mai 2024...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.21	-6.08695652174	3.45	3.59	3.07	97945	3.24023266	CS
4	-0.05	-1.51975683891	3.29	3.79	3.07	27703	3.25676567	CS
12	-1.41	-30.3225806452	4.65	4.8	3.07	12963	3.36796751	CS
26	-0.86	-20.9756097561	4.1	5.48	3.07	11346	3.72379782	CS
52	-3.16	-49.375	6.4	6.4	3.07	10880	4.06247537	CS
156	-14.36	-81.5909090909	17.6	20.52	3.07	19262	9.46127393	CS
260	-14.62	-81.8589025756	17.86	25.91	3.07	30568	14.6143244	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
POAIPredictive Oncology Inc	$ 2.5094 (134.52%)	115.59M
PBMPsyence Biomedical Ltd	$ 0.73 (86.51%)	57.25M
SLRXSalarius Pharmaceuticals Inc	$ 3.275 (53.04%)	12.92M
VKTXViking Therapeutics Inc	$ 66.02 (30.97%)	7.23M
GSHDGoosehead Insurance Inc	$ 84.79 (29.06%)	322.28k
TWOU2U Inc	$ 1.59 (-61.41%)	2.05M
EZFLEzFill Holdings Inc	$ 3.86 (-37.99%)	50.01k
KDLYKindly MD Inc	$ 2.07 (-35.71%)	427.26k
MXLMaxLinear Inc	$ 16.0199 (-28.13%)	1.85M
GLYCGlycoMimetics Inc	$ 0.2279 (-26.55%)	3.86M
NVDANVIDIA Corporation	$ 110.5146 (-3.27%)	153.92M
POAIPredictive Oncology Inc	$ 2.5094 (134.52%)	115.59M
SLNASelina Hospitality PLC	$ 0.0432 (-5.47%)	110.58M
SQQQProShares UltraPro Short QQQ	$ 9.29 (2.54%)	78.76M
STSSSharps Technology Inc	$ 0.268 (12.94%)	57.48M